title: Analysis of hemostasis alterations in sepsis.
abstract: This laboratory study tested new methods to analyze hemostasis alterations in septic patients. Samples of ethylenediamine tetraacetic acid (EDTA) plasma and citrated plasma were collected from 62 patients with clinical diagnosis of sepsis. Additionally, a subset of EDTA-plasma samples from each patient was stabilized 1 + 1 with 2.5 mol/l arginine, pH 8.6, to conserve the real hemostasis activation state. EDTA-arginine plasma, EDTA plasma and citrated plasma samples were tested in duplicate. The patients at admission to the intensive care unit had 36 +/- 26 (normal, 0.8 +/- 0.2) ng/ml global endotoxin reactivity, 188 +/- 66% (normal, 100 +/- 20%) fibrinogen function, 179 +/- 66% (normal, 100 +/- 20%) fibrinogen antigen, 4.0 +/- 3.6 (normal, 0.049 +/- 0.025) microg/ml D-dimer, 313 +/- 307% (normal, 100 +/- 30%) plasmin-antiplasmin complex, 8.7 +/- 11.4 (normal, 1.1 +/- 0.7) U/ml plasminogen activator inhibitor-1, 12.1 +/- 10.5 (normal, 1.3 +/- 0.4) ng/ml thrombin-antithrombin III complex, 173 +/- 62% (normal, 100 +/- 20%) thrombin, 568 +/- 225 (normal, 140 +/- 42) pg/ml tissue factor, and 2.56 +/- 2.48 (normal, 0.19 +/- 0.04) microg/ml soluble intercellular adhesion molecule-1. Endotoxin (lipopolysaccharide and/or beta-glucan) reactivity (EDTA plasma), fibrinogen function + antigen + ratio and plasminogen activator inhibitor-1 (citrated plasma), and D-dimer, soluble intercellular adhesion molecule-1, thrombin activity (EDTA-arginine-stabilized plasma) presented large aberrations in septic patients when compared with normal values and may therefore be particularly interesting as markers of hemostasis alteration. Whether the observed alterations are of clinical significance has to be determined in well defined patient groups.
authors.affiliation: Department of Clinical Chemistry, University Hospital Giessen and Marburg, Marburg, Germany. thstief@med.uni-marburg.de
authors.forename: Thomas W
authors.initials: TW
authors.lastname: Stief
authors.forename: Ola
authors.initials: O
authors.lastname: Ijagha
authors.forename: Bettina
authors.initials: B
authors.lastname: Weiste
authors.forename: Ileana
authors.initials: I
authors.lastname: Herzum
authors.forename: Harald
authors.initials: H
authors.lastname: Renz
authors.forename: Martin
authors.initials: M
authors.lastname: Max
mesh_terms: D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation; D006487:Hemostasis; D006801:Humans; D008722:Methods; D015539:Platelet Activation; D018805:Sepsis / Q000097:blood*
chemical_list: D015415:Biomarkers